Saba Capital Management, L.P. sold HQL

February 11, 2025 · Form 4 insider transaction

Saba Capital Management, L.P. sold 19,756 shares of Abrdn Life Sciences Investors at $13.77 per share, a transaction worth $272.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.